Drugs / Cilnidipine

Trials 5

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT01838967 Apr → Jun 2013 — IlDong Pharmaceutical Co Ltd Completed No outcome recorded
Phase 21 trial
Phase 2 NCT00890279 Jul 2009 → Jun 2010 autosomal dominant polycystic kidney disease Ministry of Health, Labour and Welfare, Japan Unknown No outcome recorded
Phase 31 trial
Phase 3 NCT02145104 Jun 2014 → Jun 2016 essential hypertension IlDong Pharmaceutical Co Ltd Completed No outcome recorded
Phase 42 trials
Phase 4 NCT00541853 Dec 2007 → Nov 2012 autosomal dominant polycystic kidney disease Kyorin University Unknown No outcome recorded
Phase 4 NCT00325936 Jul 2005 → Jun 2007 hypertensive disorder, metabolic syndrome X Boryung Pharmaceutical Co., Ltd Completed No outcome recorded
Comparator or background therapy1 trial
Phase 3 NCT00325637 Comparator Jan 2005 → Jul 2007 hypertensive disorder, ischemic stroke Boryung Pharmaceutical Co., Ltd Completed No outcome recorded

Evidence & citations 8 cited values

Every value below carries the sentence it was read from. 7 sources stand behind the page.

FieldValueCited text
Known as Cilnidipine “C - Cilnidipine 10mg will be administered orally only one time.” NCT01838967 ↗
5

NCT00325637 ↗

NCT02145104 ↗

NCT00890279 ↗

NCT00541853 ↗

NCT00325936 ↗

Known as Atelec ChEMBL registry synonym — accepted as the source's own label CHEMBL452076 ↗
Known as Cilnidipino ChEMBL registry synonym — accepted as the source's own label CHEMBL452076 ↗
Known as Cinalong ChEMBL registry synonym — accepted as the source's own label CHEMBL452076 ↗
Known as FRC-8653 ChEMBL registry synonym — accepted as the source's own label CHEMBL452076 ↗
Known as Siscard ChEMBL registry synonym — accepted as the source's own label CHEMBL452076 ↗
Modality Small molecule — CHEMBL452076 ↗
Route Oral “Cilnidipine 10\~20mg, qd, po for 4 weeks.” NCT00325637 ↗